BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2190239)

  • 1. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC
    Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
    Goldberg MP; Viseskul V; Choi DW
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
    Grigg JJ; Anderson EG
    J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
    Rothman S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):137-42. PubMed ID: 2455788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    Koek W; Colpaert FC; Woods JH; Kamenka JM
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
    Sanger DJ; Jackson A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of general anesthetic potency by agonists and antagonists of the polyamine binding site of the N-methyl-D-aspartate receptor.
    Daniell LC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):304-10. PubMed ID: 1532834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
    Koek W; Woods JH; Colpaert FC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
    France CP; Snyder AM; Woods JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):197-201. PubMed ID: 2501476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
    Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
    J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of agonists and noncompetitive antagonists at the excitatory amino acid receptors in rat retinal ganglion cells in vitro.
    Karschin A; Aizenman E; Lipton SA
    J Neurosci; 1988 Aug; 8(8):2895-906. PubMed ID: 2842467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.